Article
D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $5 Price Target
D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics (NASDAQ:QNCX) with a Buy and maintains $5 price target.
Comments
- No comments yet. Be the first to comment!